✨ Free AI Report
Repligen Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Repligen Corporation
Company Research

Repligen Corporation: Business Overview, Financials & Competitive Analysis

Repligen Corporation develops and commercializes bioprocessing technologies and systems for manufacturing biological drugs. The company serves biopharmaceutical companies, contract development and manufacturing organi...

Analyst-debate audio for Repligen Corporation

AskCyborg analysts argue the bull and bear cases for Repligen Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Repligen is well-positioned to capitalize on the structural shift toward cell/gene therapy manufacturing and domestic...

Read the full analyst-debate transcript →
Industry Life Sciences/Bioprocessing Technology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Repligen Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Repligen Corporation Overview

Pro stress-test →

Repligen Corporation develops and commercializes bioprocessing technologies and systems for manufacturing biological drugs. The company serves biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and research institutions globally, with a strategic focus on high-growth adjacent markets including cell and gene therapies.

Strategic Profile

Pro stress-test →

Repligen is positioned as a core beneficiary of biopharma reshoring trends, with over 20% order growth and expanding Edge manufacturing footprint. The company targets attractive markets including monoclonal antibodies (8-10% market growth) and is moving into cell and gene therapies (over 30% market growth).

Competitive Landscape

Pro stress-test →

Repligen competes in bioprocessing and life sciences tools, selling to biopharmaceutical companies, diagnostics firms, laboratory researchers, and contract manufacturing organizations. Primary competitors include other bioprocessing consumables suppliers such as Cytiva (part of Danaher), Sartorius, and Avantor.

Industry Context

Repligen Corporation operates in Life Sciences/Bioprocessing Technology.

Key facts

Founded: 1981 · Headquarters: Waltham, Massachusetts · Revenue: $~750M (2025 estimated) · Market cap: $7.9B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Repligen Corporation.

  • Launched three new high-performance chromatography resins (Dec 2025) targeting viral vectors and gene therapy applications
  • Over 20% order growth with expanding Edge manufacturing footprint positioning as reshoring beneficiary
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Q4 2025 earnings and full-year results reporting scheduled for February 24
  • January 2026Presented company overview at J.P. Morgan Healthcare Conference
  • +1 moreTrack every material event for Repligen Corporation as it happens. Explore monitoring →
Get alerted when Repligen Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

CytivaBioprocessing and life science tools and services→SartoriusBioprocess solutions and lab instruments→AvantorLife sciences products and services→

Compare Repligen Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Repligen Corporation operates in Life Sciences/Bioprocessing Technology. See how the rest of the sector scores on the Cyborg framework.

Browse Life Sciences/Bioprocessing Technology research →
NEW · MCP server

Ask your AI assistant about Repligen Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Repligen Corporation and its top competitor on Cyborg Score”
“What did Repligen Corporation do this quarter?”
“Is Repligen Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Repligen Corporation do?+
Repligen Corporation develops and commercializes bioprocessing technologies and systems for manufacturing biological drugs. The company serves biopharmaceutical companies, contract development and manufacturing organi...
What is Repligen Corporation's Cyborg Score?+
Repligen Corporation has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Repligen Corporation's main competitors?+
Named competitors include Cytiva, Sartorius, Avantor. The full competitive landscape is in the AskCyborg report.
How can I get the full Repligen Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Repligen Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Repligen Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Life Sciences research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Danaher Corporation8Thermo Fisher Scientific Inc.6iSpecimen Inc.6Nautilus Biotechnology, Inc.6Quanterix Corporation4Seer Inc7Sartorius Aktiengesellschaft4Avantor, Inc.